Enhancement of immune response
US5206008A · kind A · utility
62Cited by
1References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 2, 1991 |
| Grant date | Apr 27, 1993 |
| Priority date | — |
| Expiry date | Aug 2, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/15
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an improved means for regulating the immune response, for ameliorating effects of stress, and for avoiding untoward effects of chemotherapy or exposure to irradiation by administration of androstenediol (AED) and androstenetriol (AET). The improved means of regulating immune response can be utilized in treating infectious diseases and immune diseases such as diabetes and chronic fatigue syndrome, both diseases now considered to be immune response related syndromes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.